Arcus Biosciences, Inc.

RCUSNYSEUSD
22.94 USD
0.02 (0.09%)🟢LIVE (AS OF 11:22 AM EDT)
🟢Market: OPEN
Open?$22.92
High?$23.64
Low?$22.56
Prev. Close?$22.96
Volume?128.9K
Avg. Volume?1.3M
VWAP?$22.99
Rel. Volume?0.10x
Bid / Ask
Bid?$22.95 × 200
Ask?$23.01 × 200
Spread?$0.06
Midpoint?$22.98
Valuation & Ratios
Market Cap?2.9B
Shares Out?125.3M
Float?70.9M
Float %?65.6%
P/E Ratio?N/A
P/B Ratio?4.56
EPS?-$2.82
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.36Strong
Quick Ratio?4.36Strong
Cash Ratio?0.96Adequate
Debt/Equity?0.16Low
ValuationFAIRLY VALUED
Score
58/100
P/E?
N/A
P/B?
4.56FAIR
P/S?
11.65HIGH
P/FCF?
N/A
EV/EBITDA?
-7.3CHEAP
EV/Sales?
11.15HIGH
Returns & Efficiency
ROE?
-55.9%WEAK
ROA?
-31.0%WEAK
Cash Flow & Enterprise
FCF?$-351000000
Enterprise Value?$2.8B
Related Companies
Loading...
News
Profile
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Employees
601
Market Cap
2.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-03-15
Address
3928 POINT EDEN WAY
HAYWARD, CA 94545
Phone: (510) 694-6200